Thursday, October 22, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home AI & Quantum Computing

ServiceNow’s AI Surge Hits $1.5 Billion, Yet Investors Punish the Stock for What’s Missing

Kennethcix by Kennethcix
April 24, 2026
in AI & Quantum Computing, Earnings, Tech & Software
0
ServiceNow Stock
0
SHARES
95
VIEWS
Share on FacebookShare on Twitter

ServiceNow delivered a quarter that checked most boxes — revenue beat, AI bookings soaring, and guidance raised — yet the market responded with the worst single-day selloff in the company’s history. Shares tumbled roughly 18% on Thursday, settling near $85, as investors zeroed in on two cracks in the narrative: a geopolitical drag on near-term growth and margin pressure from a major acquisition.

The Numbers That Met Expectations — And the One That Didn’t

First-quarter revenue came in at $3.77 billion, edging past the consensus estimate of $3.75 billion and representing 22% year-over-year growth. Subscription revenue matched that pace, reaching $3.67 billion. Non-GAAP operating margin landed at 32%, 50 basis points above the company’s own guidance.

But the metric that rattled the Street was current remaining performance obligations (cRPO), which rose 22.5% to $12.64 billion — a whisker shy of analyst expectations. The culprit? Delayed closures of several large on-premise government contracts in the Middle East, where the ongoing regional conflict has thrown a wrench into procurement timelines. CFO Gina Mastantuono confirmed the geopolitical headwind trimmed subscription growth by 75 basis points. CEO Bill McDermott expressed confidence that most of those deals would close later this year, but the market wasn’t in a forgiving mood.

AI Momentum Accelerates, But Monetization Takes Time

The bright spot — and it’s a significant one — is the explosive growth of Now Assist, ServiceNow’s generative AI product suite. Management raised its full-year 2026 AI-specific ACV target to $1.5 billion, a 50% increase from the previous $1 billion goal. The underlying metrics are striking: customers spending more than $1 million annually on Now Assist surged over 130% year-over-year, while deals involving three or more Now Assist products jumped nearly 70% in the first quarter.

The company also signed 16 deals with net-new ACV exceeding $5 million each in the quarter, an 80% increase from a year earlier. Half of net-new business now flows through consumption-based pricing models like tokens and connectors — a structural shift management frames as an incremental growth lever rather than a threat to recurring revenue.

Should investors sell immediately? Or is it worth buying ServiceNow?

Yet the subscription-based nature of ServiceNow’s revenue model means that AI-driven acceleration takes time to show up in reported results. Stifel analysts noted that the full-year guidance remains heavily back-end loaded, with much of the expected pickup concentrated in the fourth quarter.

The Armis Hangover and Margin Math

The second source of investor unease stems from the $7.75 billion acquisition of cybersecurity firm Armis, which closed on April 20. The deal is already baked into the revised 2026 subscription revenue guidance of $15.735 billion to $15.775 billion — up from a prior midpoint of roughly $15.55 billion. But that guidance includes about 125 basis points of contribution from Armis. Strip out the acquisition, and the organic revenue outlook didn’t budge despite a strong quarter.

Margins are taking a hit too. ServiceNow now projects full-year non-GAAP subscription gross margin of 81.5%, below the 82.1% the market had penciled in. The company also trimmed its full-year non-GAAP operating margin forecast to 31.5% and free-cash-flow margin to 35%, with the Armis integration weighing on FCF by roughly 2 percentage points.

Wall Street Reacts With a Flurry of Target Cuts

The post-earnings drubbing triggered a wave of price target revisions. Goldman Sachs lowered its target from $188 to $163 while maintaining a buy rating. Jefferies cut more aggressively, from $175 to $135, though it kept a positive stance. KeyBanc struck a more bearish tone, reiterating an underweight rating with a $85 target, citing the cRPO miss and margin risks.

With the stock now roughly 52% below its 52-week high and down more than 30% year-to-date, the pressure is on management to reset the narrative. All eyes turn to the company’s Financial Analyst Day on May 4, where McDermott and his team are expected to lay out a more detailed roadmap for AI monetization and address the lingering questions about how consumption-based pricing will reshape the margin structure over the long haul.

Ad

ServiceNow Stock: Buy or Sell?! New ServiceNow Analysis from October 22 delivers the answer:

The latest ServiceNow figures speak for themselves: Urgent action needed for ServiceNow investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from October 22.

ServiceNow: Buy or sell? Read more here...

Tags: ServiceNow
Kennethcix

Kennethcix

Related Posts

Micron Technology Stock
AI & Quantum Computing

Micron’s Rally Faces Its Moment of Reckoning: A Downgrade, a Labor Standoff, and a Date With the Numbers

September 9, 2026
SAP Stock
Analysis

SAP’s Buyback Machine Grinds On, But the Analyst Chorus Is Turning Sour

September 7, 2026
Xiaomi Stock
Asian Markets

Xiaomi’s September Tightrope: A Foldable Counterpunch Against Apple While EV Targets Slip

September 7, 2026
Next Post
Nel ASA Stock

Nel ASA: New Platform Launch and US Utility Win Offer Counterweight to Order Slump

BayWa Stock

BayWa's €2.7 Billion Gap Widens as Bank Deadline Looms and Legal Troubles Mount

BYD Stock

BYD’s European Surge Masks a Brutal Home Market Slump

Recommended

BioNTech Stock

BioNTech Investors Face Legal Challenge Following CureVac Acquisition

10 months ago
Eli Lilly Stock

Eli Lilly Faces Pricing Pressure as New Regulations Force Strategic Shift

1 year ago
MMM stock news

WestPark Capital Downgrades Palo Alto Networks to Hold Rating Despite Companys Resolute Stance

3 years ago
Inmune Bio Stock

Inmune Bio Navigates Strategic Shift Amid Market Pressures

1 year ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum DroneShield Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Most Stocks Rose While the Index Fell: Earnings Week Is the Test

Tesla Jumps on a Roadster as Tech Slips Into the Weekend

CoreWeave’s Bonds Flash Red as Strong Earnings Fall Flat

Hot Core CPI Sorts the Stocks: ASML Delivers, J&J Stumbles

Goldman Delivers as Memory Stocks Slide Ahead of CPI

Optics Run Hot as Chip Leaders Pause for Breath

Trending

Bitcoin Stock
Newsletter

Lam, Tesla and Meta Clear the Bar and Still Get Sold

by Stephanie Dugan
October 22, 2026
0

Dear readers, Wednesday's open question got its answer overnight. Lam Research told investors that global spending on...

Danaher Stock

Beat Estimates, Lose Ground: Guidance Now Drives Earnings Season

October 21, 2026
Mastercard Stock

The AI Rally Needs Cheap Money, and Cheap Money Is Scarce

October 20, 2026
Meta Stock

Most Stocks Rose While the Index Fell: Earnings Week Is the Test

October 18, 2026
Tesla Stock

Tesla Jumps on a Roadster as Tech Slips Into the Weekend

October 16, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Lam, Tesla and Meta Clear the Bar and Still Get Sold
  • Beat Estimates, Lose Ground: Guidance Now Drives Earnings Season
  • The AI Rally Needs Cheap Money, and Cheap Money Is Scarce

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com